RxDoctor Payments DataLook up a doctor →

Wendy Parks

Family · Edmond, OKNPI 1346248473

Payments from drug & device makers

$11,308in general payments, 2019–2025

Across 670 payments — averaging $16.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Takeda Pharmaceuticals U.S.A., Inc.$963
  • Otsuka America Pharmaceutical, Inc.$895
  • Novo Nordisk$550
  • Lilly USA, LLC$538
  • Axsome Therapeutics, Inc.$497
  • plus $6K from 54 others

What the payments were for

  • Food & beverage$11,258100%
  • Education$500%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie141$2,047
Takeda Pharmaceuticals U.S.A., Inc.44$963
Otsuka America Pharmaceutical, Inc.64$895
Novo Nordisk34$550
Lilly USA, LLC35$538
Axsome Therapeutics, Inc.24$497
Lundbeck LLC25$495
IBSA Pharma Inc.26$448
Amneal Pharmaceuticals LLC26$411
Pfizer24$404
Supernus Pharmaceuticals, Inc.20$361
Corium, LLC14$251
GSK13$221
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)10$193
Azurity Pharmaceuticals, Inc.9$167
Corcept Therapeutics8$166
Astellas Pharma US Inc8$151
Currax Pharmaceuticals LLC9$142
Mayne Pharma Commercial LLC11$135
Antares Pharma, Inc.7$126
Exact Sciences7$123
Abbott5$104
Sunovion Pharmaceuticals Inc.5$99
Biohaven Pharmaceutical Holding Company Ltd.5$94
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$92
Nestle Healthcare Nutrition Inc.5$90
Ironwood Pharmaceuticals, Inc5$88
Radius Health, Inc.4$86
Bayer5$86
Acella Pharmaceuticals, LLC5$82
Intra-sana Laboratories5$79
Idorsia Pharmaceuticals US Inc4$74
Medtronic1$73
Amgen(2 entities)4$69
Noven Therapeutics, LLC4$67
Arbor Pharmaceuticals, Inc.5$66
Sumitomo Pharma America, Inc.3$64
Avion Pharmaceuticals3$55
Bausch Health US, LLC3$54
Ironshore Pharmaceuticals Inc.3$54
Teva Pharmaceuticals USA, Inc.3$49
Adlon Therapeutics L.p.3$43
Biohaven Pharmaceuticals, Inc.2$42
Clarus Therapeutics Inc.2$36
Jazz Pharmaceuticals Inc.2$33
ANI Pharmaceuticals, Inc.1$31
Impel Pharmaceuticals Inc.2$30
Dexcom, Inc.1$29
Therapeuticsmd, Inc.2$29
Millicent US Inc2$29
Gilead2$27
Upsher-smith Laboratories LLC1$21
Neos Therapeutics, LP1$21
Optinose US, Inc.1$21
Collegium Pharmaceutical, Inc.1$20
Halozyme Inc1$19
Ascend Therapeutics US, LLC1$19
Ardelyx, Inc.1$18
Johnson & Johnson1$17
Kowa Pharmaceuticals America, Inc.1$16

How this compares

$11,308 in reported general payments places this provider in the 95th percentile of 2,026 family providers in Oklahoma.

See all family providers in Oklahoma

Medicare billing

Part B allowed, 2024
$35,373
Medicare patients
167
Services billed
1,162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide145$190,969
OzempicSemaglutide36$36,470
TrulicityDulaglutide18$19,939
RexultiBrexpiprazole13$18,991
SynthroidLevothyroxine Sodium150$16,583
MyrbetriqMirabegron13$11,111
PremarinEstrogens, Conjugated18$5,978
Atomoxetine Hcl12$3,975
ProgesteroneProgesterone, Micronized94$3,583
Liothyronine Sodium63$3,252
EstrogelEstradiol11$2,975
Levothyroxine Sodium215$2,358
Desvenlafaxine Succinate ErDesvenlafaxine Succinate32$2,198
Armour ThyroidThyroid,pork20$2,022
Bupropion XlBupropion Hcl41$1,663

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$538$210,907163 claims
Novo NordiskOzempic$550$36,47036 claims
Otsuka America Pharmaceutical, Inc.Rexulti$895$18,99113 claims
AbbVieSynthroid, Armour Thyroid$2,047$18,604170 claims
Astellas Pharma US IncMyrbetriq$151$11,11113 claims
PfizerPremarin$404$5,97818 claims
Ascend Therapeutics US, LLCEstrogel$19$2,97511 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$411$2,358215 claims
Acella Pharmaceuticals, LLCNp Thyroid$82$94320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,026 family providers in Oklahoma.

Other family in Edmond

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →